Cumulative prevalence of atopic eczema and related skin symptoms in a well-baby clinic: a retrospective cohort study.
The aim of the study was to assess the frequency and treatment policy of atopic eczema (AE) and related skin symptoms including rash, redness, dryness and itch in 0- to 5-year-old children. Health records of 320 children born in 1994 were systematically studied. The main results were that 77% of children suffered from skin symptoms during their first 5 years while the cumulative prevalence of AE was 16%, and 11% of children with skin symptoms were referred to a specialist. AE and related skin symptoms were common in the first 5 years of life, and were mostly temporary and responsive to topical treatment. Well-baby clinics play a key role in the treatment of skin-symptomatic children.
Lehtonen
Elina Pia-Maria
EP
Department of General Practice, Medical School, University of Tampere Paediatric Research Center, Tampere University Hospital and University of Tampere, Tampere, Finland. elina.pm.lehtonen@uta.fi
Holmberg-Marttila
Doris
D
Kaila
Minna
M
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000367:Age Factors; D000553:Ambulatory Care; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002662:Child Health Services; D002669:Child Welfare; D002675:Child, Preschool; D015331:Cohort Studies; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D005076:Exanthema / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D005260:Female; D005387:Finland / Q000453:epidemiology; D005512:Food Hypersensitivity / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D005865:Gestational Age; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007229:Infant Welfare; D007231:Infant, Newborn; D008297:Male; D015995:Prevalence; D012189:Retrospective Studies; D012720:Severity of Illness Index; D012867:Skin / Q000187:drug effects / Q000473:pathology*; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists